Bioxcel Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bioxcel Therapeutics by BlackRock
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $564k | 441k | 1.28 |
2024-03-31 | $3.7M | 1.3M | 2.82 |
2023-09-30 | $3.3M | 1.3M | 2.53 |
2023-06-30 | $9.3M | 1.4M | 6.66 |
2023-03-31 | $26M | 1.4M | 18.66 |
2022-12-31 | $31M | 1.5M | 21.48 |
2022-06-30 | $19M | 1.4M | 13.22 |
2021-06-30 | $33M | 1.1M | 29.04 |
2021-03-31 | $46M | 1.1M | 43.17 |
2020-12-31 | $42M | 900k | 46.20 |
2020-09-30 | $35M | 810k | 43.37 |
2020-03-31 | $11M | 499k | 22.40 |
2019-12-31 | $5.8M | 401k | 14.59 |
2019-09-30 | $2.2M | 309k | 7.06 |
2019-06-30 | $3.3M | 299k | 10.88 |
2019-03-31 | $143k | 14k | 9.98 |
2018-12-31 | $61k | 15k | 3.99 |
2018-09-30 | $124k | 16k | 7.98 |
2018-06-30 | $134k | 15k | 8.98 |